Neoadjuvant therapy for resectable pancreatic cancer
The use of neoadjuvant therapies has played a major role for borderline resectable and locally advanced pancreatic cancers(PCs). For this group of patients, preoperative chemotherapy or chemoradiation has increased the likelihood of surgery with negative resection margins and overall survival. On th...
Saved in:
Published in | World journal of gastrointestinal oncology Vol. 9; no. 12; pp. 457 - 465 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
China
Baishideng Publishing Group Inc
15.12.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!